PapersPMID:20016733
A randomized study to establish the effects of spirulina in type 2 diabetes mellitus patients.
- findings
- 2
- compound
- 1
- endpoints
- 2
- Study, every finding
- RCT · 3 months
- Dose studied, every finding
- 8.0 g/day as 40 pills of 0.2 g
- Population, every finding
- Korean adults with type 2 diabetes recruited from a diabetes clinic; control group received no intervention and kept usual diet
What moved
How to read these marks →- Increases serum adiponectin
moderate
“Repeated test for treatment showed significant effects of spirulina supplementation on lowering plasma MDA (time × treatment interaction, p<0.05) and on increasing adiponectin concentration (time × treatment interaction, p<0.05).”
- Decreases triglycerides
moderatereplicated ×4
“Spirulina supplementation showed a significant lowering effect on plasma triglyceride level and diastolic blood pressure by repeated test for treatment (time × treatment interaction, p<0.05).”
Study record
- Design
- randomised controlled trial
- Species
- human
- Population
- Korean patients with type 2 diabetes mellitus recruited from a diabetes clinic in Seoul
- Participants
- 37
- Comparator
- no treatment
- Duration
- 84 days
- Endpoints measured
- 33